Clinical Trial: A Study to Learn How Different Amounts of the Study Medicine Called PF-08161842 Are Tolerated and Act in the Body in Healthy and Older Adults

U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07897708) titled 'A Study to Learn How Different Amounts of the Study Medicine Called PF-08161842 Are Tolerated and Act in the Body in Healthy and Older Adults' on Oct. 20.

Brief Summary: The purpose of this clinical study is to learn about the safety and effects of the study medicine (called PF-08161842) and how it is processed by the body. This is the first time PF-08161842 will be given to people.

This study is seeking healthy adults:

* 18 to 64 years of age or 65 to 85 years of age

* Who are in generally good health

* Who meet study conditions for body weight and body mass index (BMI)

Participants will receive either PF-08161842 tablets or m...